Streetbeat News

Regulatory

ALK

HA

The U.S. Department of Transportation has granted Alaska Airlines and Hawaiian Airlines a temporary exemption for common ownership under Alaska Air Group. This is pending a final decision on the transfer of route authority.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 6:26 pm

EIS

ISRA

SPY

The U.S. State Department is seeking a diplomatic resolution to the Israel-Hezbollah conflict and is concerned about potential escalation in the Middle East. The department urges Iran not to exploit the situation and states it's too early to assess the impact of a recent attack on Gaza ceasefire talks.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 6:00 pm

TSLA

Elon Musk announced on X that SpaceX will be filing a lawsuit against the FAA, accusing it of regulatory overreach. This legal action could impact SpaceX's operations and its relationship with regulatory bodies.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 5:40 pm

MRNA

Moderna's shares are rising after Health Canada approved its updated COVID-19 vaccine, SPIKEVAX, targeting the KP.2 variant. The approval is based on comprehensive data supporting the vaccine's efficacy and safety.

Portfolio Pulse from Dylan Berman

September 17, 2024 | 5:30 pm

BTCUSD

DOGEUSD

ETHUSD

Cryptocurrency markets are anticipating the Federal Reserve's decision on interest rate cuts, with potential impacts on Bitcoin, Ethereum, and Dogecoin. Jim Bianco highlights concerns about aggressive rate cuts and their implications for inflation. Despite Bitcoin ETFs' hype, they haven't attracted new money, with existing holders moving assets to brokerage accounts.

Portfolio Pulse from Khyathi Dalal

September 17, 2024 | 5:11 pm

FANG

Oil company shares are rising due to supply uncertainties from Gulf of Mexico disruptions and Middle East tensions. Investors are also anticipating potential Fed rate cuts, which could boost demand.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 5:09 pm

X

U.S. Steel's CEO has described the national security review of Nippon Steel's bid for the company as 'very robust' and expressed confidence that the bid will close on its merits.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 5:06 pm

NVS

The FDA has approved Novartis' drug Kisqali for reducing the risk of recurrence in patients with HR+/HER2- early breast cancer. This approval could potentially boost Novartis' market position in the oncology sector.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 5:05 pm

DDD

3D Systems shares rose following FDA clearance for its monolithic jetted denture solution, indicating potential growth in its healthcare segment.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 4:35 pm